2024 Partners
imu Biosciences
Innovation Partner
The imu platform provides a massively scalable, high-resolution immune profiling, capturing a systems level view of an individual's immune system consisting of >2000 immune cell subsets. Using this data we can screen candidate donors identifying those that will generate consistent, high yield, cell therapy products. The same platform and analytics can also provide a new level of understanding of cell therapy product characteristics and an understanding of how patients respond to therapy in the clinic.
ScaleReady
Exhibition Partner
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. Our platform includes G-Rex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.
Lonza
Program partner
Lonza’s Cell & Gene offering spans across development and manufacturing services, products, solutions, testing and automation platforms as well as tools and technologies to enable you to develop, de-risk and industrialize your therapy, from basic research to commercialization.
United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.